Adverts

Open Access Articles- Top Results for AM-630

AM-630

</th></tr>
AM-630
200px
Systematic (IUPAC) name
1-[2-(morpholin-4-yl)ethyl]-2-methyl-3-(4-methoxybenzoyl)-6-iodoindole
Clinical data
Identifiers
164178-33-0 7pxN
PubChem CID 4302963
ChemSpider 3508738 7pxY
ChEMBL CHEMBL181633 7pxY
Chemical data
Formula C23H25IN2O3
504.360 g/mol
 14pxN (what is this?)  (verify)

AM-630 (6-Iodopravadoline) is a drug that acts as a potent and selective inverse agonist for the cannabinoid receptor CB2, with a Ki of 32.1nM at CB2 and 165x selectivity over CB1, at which it acted as a weak partial agonist.[1][2] It is used in the study of CB2 mediated responses and has been used to investigate the possible role of CB2 receptors in the brain.[3][4] AM-630 is significant as one of the first indole derived cannabinoid ligands substituted on the 6-position of the indole ring, a position that has subsequently been found to be important in determining affinity and efficacy at both the CB1 and CB2 receptors, and has led to the development of a large number of related derivatives.[5][6][7][8][9]

See also

References

  1. Ross RA et al. (February 1999). "Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630". British Journal of Pharmacology 126 (3): 665–72. PMC 1565857. PMID 10188977. doi:10.1038/sj.bjp.0702351. 
  2. Murataeva, N.; MacKie, K.; Straiker, A. (2012). "The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons". Pharmacological Research 66 (5): 437–42. PMC 3601544. PMID 22921769. doi:10.1016/j.phrs.2012.08.002.  edit
  3. Morgan NH, Stanford IM, Woodhall GL (September 2009). "Functional CB2 type cannabinoid receptors at CNS synapses". Neuropharmacology 57 (4): 356–68. PMID 19616018. doi:10.1016/j.neuropharm.2009.07.017. 
  4. Ishiguro H et al. (May 2010). "Brain cannabinoid CB2 receptor in schizophrenia". Biological Psychiatry 67 (10): 974–82. PMID 19931854. doi:10.1016/j.biopsych.2009.09.024. 
  5. Eissenstat, M. A.. et al. (1995). "Aminoalkylindoles: Structure-Activity Relationships of Novel Cannabinoid Mimetics". Journal of Medicinal Chemistry 38 (16): 3094–105. PMID 7636873. doi:10.1021/jm00016a013.  edit
  6. Hongfeng Deng. Design and synthesis of selective cannabinoid receptor ligands: Aminoalkylindole and other heterocyclic analogs. PhD Dissertation, University of Connecticut, 2000.
  7. Hynes J et al. (September 2002). "C-3 Amido-indole cannabinoid receptor modulators". Bioorganic & Medicinal Chemistry Letters 12 (17): 2399–402. PMID 12161142. doi:10.1016/S0960-894X(02)00466-3. 
  8. Frost, J. M. et al. (2008). "Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB2 Cannabinoid Receptor Activity". Journal of Medicinal Chemistry 51 (6): 1904–12. PMID 18311894. doi:10.1021/jm7011613.  edit
  9. doi:10.1039/c0md00022a
    This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand


Lua error in package.lua at line 80: module 'Module:Buffer' not found.